Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.

NCT04641364 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Ascites

Interventions

DRUG: recombinant human albumin injection
DRUG: Placebo
DRUG: human albumin injection

Sponsor

The First Hospital of Jilin University